News

A groundbreaking brain imaging study from Wake Forest University School of Medicine confirms a vital step toward new ...
You probably have a bottle of this over-the-counter drug in your medicine cabinet right now. It’s been a go-to for headaches, colds, and allergies for decades. But now, two countries have banned it.
Esketamine monotherapy demonstrated beneficial antidepressant effects at multiple doses for patients with treatment-resistant depression, according to results of a phase 4 randomized trial published ...
Decongestants with the same brand name may contain two different active ingredients. And, by nearly every account, one of them doesn’t work.
New and disturbing concerns about fake GLP-1 drugs are cited in a letter sent to the FDA by Tennessee officials, including Sen. Marsha Blackburn.
The Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in a Complete Response Letter (CRL) for etripamil nasal spray (Cardamyst ™ ), an investigational ...
Chronic rhinosinusitis with nasal polyps increases the likelihood of developing coexisting conditions, such as asthma, underscoring the need for more effective, comprehensive treatments.
Oxytocin, often called the “love hormone” for its role in social bonding and maternal behaviors, is now being investigated for something unexpected—its ability to regulate addictive behaviors and ...
Today’s health headlines: ketamine nasal sprays offer a new option for people with treatment-resistant depression. Plus, how ...
People with hay fever could one day benefit from a first-of-its-kind “molecular shield” that blocks pollen from entering the ...